tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:6BG Stock Latest News

Lytix Biopharma’s Oncolytic Peptide Platform Gains Visibility with New JITC Review
Company AnnouncementsLytix Biopharma’s Oncolytic Peptide Platform Gains Visibility with New JITC Review
6d ago
6BG
Lytix Biopharma Advances Ruxotemitide Program as Strong Phase II Data and Cost Discipline Mark 2025
PremiumCompany Announcements
Lytix Biopharma Advances Ruxotemitide Program as Strong Phase II Data and Cost Discipline Mark 2025
11d ago
6BG
Lytix Biopharma Raises NOK 16.3 Million in Subsequent Share Offering
PremiumCompany Announcements
Lytix Biopharma Raises NOK 16.3 Million in Subsequent Share Offering
13d ago
6BG
Lytix Biopharma’s NOK 30 Million Subsequent Share Offering Closes Today
PremiumCompany Announcements
Lytix Biopharma’s NOK 30 Million Subsequent Share Offering Closes Today
13d ago
6BG
Lytix Biopharma Schedules Webcast for Fourth-Quarter and Second-Half 2025 Results
PremiumCompany Announcements
Lytix Biopharma Schedules Webcast for Fourth-Quarter and Second-Half 2025 Results
18d ago
6BG
Lytix Biopharma Launches Subsequent Share Offering Following NOK 61 Million Private Placement
PremiumCompany AnnouncementsLytix Biopharma Launches Subsequent Share Offering Following NOK 61 Million Private Placement
27d ago
6BG
Lytix Biopharma Wins Shareholder Backing for NOK 30m Offering and Conversion to Public Company
Premium
Company Announcements
Lytix Biopharma Wins Shareholder Backing for NOK 30m Offering and Conversion to Public Company
28d ago
6BG
Lytix Biopharma Registers NOK 61 Million Private Placement, Expands Share Capital
Premium
Company Announcements
Lytix Biopharma Registers NOK 61 Million Private Placement, Expands Share Capital
1M ago
6BG
Lytix Biopharma Calls EGM for NOK 30m Repair Offering and Conversion to Public Company
PremiumCompany Announcements
Lytix Biopharma Calls EGM for NOK 30m Repair Offering and Conversion to Public Company
1M ago
6BG
Insider-Linked Investor Takes Major Allocation in Lytix Biopharma Share Issue
PremiumCompany Announcements
Insider-Linked Investor Takes Major Allocation in Lytix Biopharma Share Issue
1M ago
6BG
Lytix Biopharma Lines Up NOK 30m Subsequent Share Offering After Private Placement
PremiumCompany Announcements
Lytix Biopharma Lines Up NOK 30m Subsequent Share Offering After Private Placement
1M ago
6BG
Lytix Biopharma Raises NOK 61 Million in Oversubscribed Private Placement and Plans Repair Offering
PremiumCompany Announcements
Lytix Biopharma Raises NOK 61 Million in Oversubscribed Private Placement and Plans Repair Offering
2M ago
6BG
Lytix Biopharma’s Promising Update: Phase 2 Study on Advanced Melanoma Treatment Completed
PremiumCompany AnnouncementsLytix Biopharma’s Promising Update: Phase 2 Study on Advanced Melanoma Treatment Completed
2M ago
6BG
Lytix Biopharma to Release Q3 2025 Financial Results
Premium
Company Announcements
Lytix Biopharma to Release Q3 2025 Financial Results
3M ago
6BG
Lytix Biopharma Reports Promising Interim Results in Melanoma Study
Premium
Company Announcements
Lytix Biopharma Reports Promising Interim Results in Melanoma Study
3M ago
6BG
Lytix Biopharma’s Ruxotemitide Shows Promising Results in Cancer Immunotherapy
PremiumCompany Announcements
Lytix Biopharma’s Ruxotemitide Shows Promising Results in Cancer Immunotherapy
4M ago
6BG
Lytix Biopharma’s Partner to Present Promising Phase II Trial Data at SITC
PremiumCompany Announcements
Lytix Biopharma’s Partner to Present Promising Phase II Trial Data at SITC
5M ago
6BG
Lytix Biopharma Strengthens Management Incentives with Share Options
PremiumCompany Announcements
Lytix Biopharma Strengthens Management Incentives with Share Options
6M ago
6BG
Lytix Biopharma Advances Ruxotemitide in Cancer Treatment with Promising H1 2025 Results
PremiumCompany Announcements
Lytix Biopharma Advances Ruxotemitide in Cancer Treatment with Promising H1 2025 Results
6M ago
6BG
Lytix Biopharma to Announce Q2 2025 Financial Results
PremiumCompany AnnouncementsLytix Biopharma to Announce Q2 2025 Financial Results
6M ago
6BG
Lytix Biopharma Grants Share Options to Board Members
Premium
Company Announcements
Lytix Biopharma Grants Share Options to Board Members
9M ago
6BG
Lytix Biopharma Reports Strong Q1 2025 Results and Strategic Advancements
Premium
Company Announcements
Lytix Biopharma Reports Strong Q1 2025 Results and Strategic Advancements
9M ago
6BG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >